Explaining the uptake of paediatric guidelines in a Kenyan tertiary hospital--mixed methods research

Grace W Irimu1, Alexandra Greene, David Gathara

  • 1Department of Paediatrics and Child Health, College of Health Sciences, University of Nairobi, P,O, Box 19676-00202, Nairobi, Kenya. girimu06@yahoo.com.

Insights

Translating evidence-based pediatric guidelines into practice is complex and unpredictable. Organizational and professional factors significantly impact healthcare quality improvement, requiring long-term strategies for effective implementation.

Area of Science:

  • Pediatric Healthcare Quality Improvement
  • Knowledge Translation in Medicine
  • Health Services Research

Background:

  • Evidence-based standards for pediatric care exist but face challenges in clinical practice implementation.
  • Institutional context and organization are key determinants of successful guideline translation.
  • Research on the dynamic nature of these determinants in quality improvement is limited.

Purpose of the Study:

  • To explore the uptake of locally adapted pediatric guidelines in a low-income country tertiary hospital.
  • To investigate the dose-effect relationship of an intervention aimed at improving guideline adherence.
  • To understand the complex factors influencing the translation of best practices in pediatric care.

Main Methods:

  • Mixed methods research combining quantitative (before-and-after study) and qualitative (ethnographic) approaches.
  • Intervention dose-effect relationship explored in a tertiary hospital setting.
  • Interpretive integration of data to derive meta-inferences on the phenomenon studied.

Main Results:

  • Health worker performance improvement was not linear with intervention intensity, showing variability.
  • Root causes for performance variability included challenges in knowledge updates, staff commitment, role modeling, teamwork, and institutional pressures.
  • Mal-adaptation to institutional pressures and maintaining professional integrity were identified issues.

Conclusions:

  • Best-practice implementation is complex and unpredictable due to professional and organizational factors.
  • No simple solutions exist; long-term planning focusing on ethics, values, and organizational frameworks is needed.
  • Study has implications for medical training quality and hospital leadership development.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
3.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K